Fulgent Genetics
FLGT
174 hedge funds and large institutions have $300M invested in Fulgent Genetics in 2024 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 59 increasing their positions, 48 reducing their positions, and 34 closing their positions.
5,961% more call options, than puts
Call options by funds: $40.6M | Put options by funds: $670K
23% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 48
1.3% more ownership
Funds ownership: 49.73% → 51.03% (+1.3%)
3% less funds holding
Funds holding: 180 → 174 (-6)
7% less capital invested
Capital invested by funds: $322M → $300M (-$22.7M)
12% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 34
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$5.11M |
| 2 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
+$3.34M |
| 3 |
Morgan Stanley
New York
|
+$3.11M |
| 4 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
+$2.62M |
| 5 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$2.16M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nuveen
Charlotte,
North Carolina
|
-$3.58M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$2.69M |
| 3 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$2.59M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.78M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.41M |
FLGT Hedge Fund Activity: Q2 2024 in Review
174 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q2 2024, worth a combined $300M — down 7% from $322M a quarter earlier.
Sellers outnumbered buyers: 34 funds closed out of FLGT and 30 opened new positions — a net loss of 4 holders — while 48 trimmed existing stakes and 59 added.
The largest buyer was Millennium Management, adding an estimated $5.11M. The largest seller was Nuveen, cutting an estimated $3.58M.
- 174 institutional investors held Fulgent Genetics (FLGT) as of Q2 2024, down from 180 in Q1 2024.
- Funds reported $300M of Fulgent Genetics stock for Q2 2024, down 7% quarter-over-quarter.
- 30 funds opened new Fulgent Genetics positions in Q2 2024 and 34 closed out, a net change of -4 holders.
- The largest Fulgent Genetics buyer in Q2 2024 was Millennium Management, an estimated $5.11M added.
- The largest Fulgent Genetics seller in Q2 2024 was Nuveen, an estimated $3.58M sold.
Based on aggregated 13F filings for Q2 2024.